tenx_ex231

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-167175, 333-196464, 333-210182, 333-224120, and 333-233571), Form S-3 (No. 333-224951), and Form S-1 (No. 333-228212) of our report dated March 30, 2020 included in this Annual Report on Form 10-K of Tenax Therapeutics, Inc. and Subsidiary (the “Company”), relating to the consolidated balance sheets of the Company as of December 31, 2019 and 2018, and the related consolidated statements of operations and comprehensive loss, stockholders’ equity, and cash flows, and the related notes (which report expresses an unqualified opinion and contains an explanatory paragraph regarding substantial doubt about the Company’s ability to continue as a going concern) for each of the years in the two-year period ended December 31, 2019.